BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32880616)

  • 1. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth.
    Wolf RM; Liu TYA; Thomas C; Prichett L; Zimmer-Galler I; Smith K; Abramoff MD; Channa R
    Diabetes Care; 2021 Mar; 44(3):781-787. PubMed ID: 33479160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
    Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
    PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management.
    Lin T; Gubitosi-Klug RA; Channa R; Wolf RM
    Curr Diab Rep; 2021 Dec; 21(12):56. PubMed ID: 34902076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period.
    Bai P; Barkmeier AJ; Hodge DO; Mohney BG
    JAMA Ophthalmol; 2022 Jan; 140(1):51-57. PubMed ID: 34854892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Automated Screening for Referable Diabetic Retinopathy With an Autonomous Diagnostic Artificial Intelligence System in a Spanish Population.
    Shah A; Clarida W; Amelon R; Hernaez-Ortega MC; Navea A; Morales-Olivas J; Dolz-Marco R; Verbraak F; Jorda PP; van der Heijden AA; Peris Martinez C
    J Diabetes Sci Technol; 2021 May; 15(3):655-663. PubMed ID: 32174153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness.
    Tufail A; Kapetanakis VV; Salas-Vega S; Egan C; Rudisill C; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Bailey C; Sadda S; Taylor P; Rudnicka AR
    Health Technol Assess; 2016 Dec; 20(92):1-72. PubMed ID: 27981917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.
    Ipp E; Liljenquist D; Bode B; Shah VN; Silverstein S; Regillo CD; Lim JI; Sadda S; Domalpally A; Gray G; Bhaskaranand M; Ramachandra C; Solanki K;
    JAMA Netw Open; 2021 Nov; 4(11):e2134254. PubMed ID: 34779843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy screening in a Canadian community pediatric diabetes clinic.
    Abdella K; McReelis KD; Strungaru MH
    Can J Ophthalmol; 2019 Feb; 54(1):27-32. PubMed ID: 30851771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
    Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
    JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
    Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
    Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
    Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
    Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
    Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
    Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.
    Porter M; Channa R; Wagner J; Prichett L; Liu TYA; Wolf RM
    Pediatr Diabetes; 2020 Aug; 21(5):856-862. PubMed ID: 32410329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of detecting and treating diabetic retinopathy.
    Javitt JC; Aiello LP
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):164-9. PubMed ID: 8554212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
    Morrison SL; Dukhovny D; Chan RVP; Chiang MF; Campbell JP
    JAMA Ophthalmol; 2022 Apr; 140(4):401-409. PubMed ID: 35297945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy.
    Walton OB; Garoon RB; Weng CY; Gross J; Young AK; Camero KA; Jin H; Carvounis PE; Coffee RE; Chu YI
    JAMA Ophthalmol; 2016 Feb; 134(2):204-9. PubMed ID: 26720694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.
    Keenum Z; McGwin G; Witherspoon CD; Haller JA; Clark ME; Owsley C
    JAMA Ophthalmol; 2016 Nov; 134(11):1221-1228. PubMed ID: 27632231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of diabetic retinopathy in type 1 diabetes in a diabetes care center in South India-Feasibility and awareness improvement study.
    Rajalakshmi R; Shanthirani CS; Anandakumar A; Anjana RM; Murthy GVS; Gilbert C; Mohan V
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S92-S95. PubMed ID: 31937740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.